Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model

MLA

Bruno Housset, et al. “Routine Use of Granulocyte Colony-Stimulating Factor Is Not Cost-Effective and Does Not Increase Patient Comfort in the Treatment of Small-Cell Lung Cancer: An Analysis Using a Markov Model.” Journal of Clinical Oncology, vol. 16, Aug. 1998, pp. 2700–07. EBSCOhost, https://doi.org/10.1200/jco.1998.16.8.2700.

APA

Bruno Housset, Christos Chouaid, Claire Fuhrman, Isabelle Monnet, & L Bassinet. (1998). Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model. Journal of Clinical Oncology, 16, 2700–2707. https://doi.org/10.1200/jco.1998.16.8.2700

Chicago

Bruno Housset, Christos Chouaid, Claire Fuhrman, Isabelle Monnet, and L Bassinet. 1998. “Routine Use of Granulocyte Colony-Stimulating Factor Is Not Cost-Effective and Does Not Increase Patient Comfort in the Treatment of Small-Cell Lung Cancer: An Analysis Using a Markov Model.” Journal of Clinical Oncology 16 (August): 2700–2707. doi:10.1200/jco.1998.16.8.2700.